How deadly is Alzheimer?

['A lamɛn']

O bana be mɔgɔ faga cogo di?

O bana be mɔgɔ hakili ɲagami ani a tɛ se ka miiri koɲuman.

O bana be mɔgɔ caaman minɛ ka tɛmɛ bana tɔw bɛɛ kan.

A ka jugu ka tɛmɛ bana tɔw bɛɛ kan. Mɔgɔ dɔw be se ka saan 20 sɔrɔ ka bana in to u la.

O bana be mɔgɔ minw faga, u hakɛ tɛ kelen ye.

Alzheimer ka jɛnkulu ka fɔ la, Alzheimer bana ye saya sababu wɔɔrɔnan ye Etazini jamana na, ani saya sababu duurunan mɔgɔ 65 ni kɔ fɛ.

Saan 2019, Alzeimɛri bana tun jatiminɛna ka kɛ mɔgɔ 121,9444 ka saya sababu ye Etazini jamana na.

A kɔrɔtanin lo an k'a faamu ko mɔgɔ minw ka saya sababu ye bana ye, o tɛ kɛ bana yɛrɛ ye.

Ni bana juguyara, a tigi ka teli ka gɛlɛya a ka loon o loon baaraw la, i n'a fɔ dumuni, ko ani fani donni.

Ka fara o kan, bana minw ka teli ka mɔgɔ minɛ, u dɔw ye benkanniw, sumaya ani bana wɛrɛw ye.

Hali ni sisan yɛrɛ, bana in furakɛli tɛ yen, fura dɔw be yen minw be se k'a ka bana taamasiɲɛw nɔgɔya ani k'a tigi ka ɲɛnamaya kɛcogo fisaya.

O kama, u be ɲinini kɛra walisa ka furaw sɔrɔ bana jugu nin na.

['Kunnafoni wɛrɛw']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.

Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.

Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.

Mortality from Alzheimer disease--United States, 1979-1987. MMWR Morb Mortal Wkly Rep. 1990, 39 (43): 785-8.

Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.

Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.

['Kunnafoni nafaman: furakɛli']

["O site web nin labɛnna walisa ka mɔgɔw kalan ani k'u kunnafoni dɔrɔn."]

["Mɔgɔ minw b'o gafew kalan, olu man kan k'u kɛ ka bana dɔw furakɛ."]

['Aw ye aw janto nin na: ɛntɛrinɛti min bɛ ɲiningaliw jaabiw labɛn, a tɛ se ka jatidenw fɔ ka ɲɛ. misali la, bana kɛrɛnkɛrɛnnen dɔ bɛ mɔgɔ minw na.']

["Tuma bɛɛ i ka kan ka ladili ɲini i ka dɔgɔtɔrɔ fɛ wala kɛnɛya baarakɛla dɔ fɛ bana dɔ koo la. I kana ban ka ladili ɲini dɔgɔtɔrɔ fɛ wala ka mɛɛn a ɲinili la sabu i ye koo dɔ kalan site web nin kan. N'i miirila ko bana dɔ be i kan, i ka kan ka teliya ka mɔgɔ wele 911 wala ka taga dɔgɔtɔrɔso la joona joona."]

['Kunnafoniw: sɛbɛkɔrɔ']

["Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) ye sariya dɔ ye min b'a to mɔgɔ minw b'u ka gafew sɔrɔ ɛntɛrinɛti kan, olu ka se k'u yɛrɛ lafasa."]

["N'i lanin b'a la ko kunnafoni wala fɛɛn o fɛɛn be sɔrɔ an ka site web kan wala an ka baaraw kan, k'o be i ka sariya tiɲɛ, i (wala i ka lasigiden) be se k'o kunnafoni wala fɛɛn bɔ yen wala k'a bali k'a sɔrɔ."]

['I ka kan ka ci nin ci nin kɛ e-mail fɛ (i ka e-mail lajɛ yɔrɔ nin na)']

["DMCA b'a ɲini ko i ka kunnafoni nunu fara i ka kunnafoni kan: (1) kunnafoni min b'a yira ko i ye baara dɔ kɛ min ka kan ni sariya ye; (2) kunnafoni min b'a yira ko i ye baara dɔ kɛ min ma sariya labato ani kunnafoni wɛrɛw minw b'a to an be se k'o kunnafoni sɔrɔ; (3) i ka ladɛrɛsi, telefɔni nimɔrɔ ani e-mail; (4) i ka seereya dɔ ko i lanin b'a la ko i ye baara min kɛ, ko sariya t'o kɛ."]

["5. i ka sɛbɛ dɔ kɛ ka yira ko i ye tiɲɛn fɔ ani ko joo b'i fɛ ka joo dɔ latanga."]

["O kama, a ka ɲi i k'a ɲini k'a lɔn n'i ka ɲi k'o gafew wala videwo nunu jati k'u ye gafew ye minw labɛnna mɔgɔw ye."]

["N'i ma kunnafoni nunu bɛɛ di, a be se ka kɛ ko i ka ɲinini baara be mɛɛn."]

['Kumaɲɔgɔnya kɛ']

["N'i ka ɲiningaliw wala i ka ladiliw be yen, an ci e-mail fɛ."]

How deadly is alzheimer?

Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.

It is the most common cause of dementia, accounting for 60-80% of all cases.

The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.

The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.

According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.

In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.

It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.

As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.

Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.

While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.

Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.